CIGNA / EXPRESS SCRIPTS
The following are the public documents filed in connection with the application and request by Cigna Corporation, a Delaware corporation, and
Halfmoon Parent, Inc., a Delaware corporation wholly-owned by Cigna
Corporation, to acquire control of Medco Containment
Life Insurance Company, a Pennsylvania domiciled life insurance company and
indirect wholly-owned subsidiary of Express Scripts Holding Company, Inc.
How to Submit a Public Comment - Individuals wishing to comment on the filing on the ground of public or private interest in the filing are invited to submit a written statement on the filing to the department. Written statements must include the name, address and telephone number of the person making the statement, identification of the application to which the statement is addressed and a concise statement with sufficient details and relevant facts to inform the department of the exact basis of the statement. Written statements should be directed to Cressinda Bybee, Company Licensing Division, Pennsylvania Insurance Department, 1345 Strawberry Square, Harrisburg, PA 17120, fax (717) 787-8557,
cbybee@pa.gov.
Comments received will be part of the public record regarding the filing and will be made available on the Insurance Department's website. Additionally, copies of the comments received will be forwarded to the applicant for appropriate response. The applicant's response will also be made available on the Insurance Department's website.
001
|
PA Form A Index |
002 |
Cover Letter |
003 |
Filing Fee |
004 |
Form A - Executed |
005 |
Exhibit A - Merger
Agreement |
006 |
Exhibit B - Transactiion
Steps Diagram |
007 |
Exhibit C1 - Cigna's 8-K
filed 3/8/18 |
008 |
Exhibit C2 - Cigna's 8-K,
filed 3/13/18 |
009 |
Exhibit D - Cigna's Form
10-K (2013-2017) |
010 |
Exhibit E1 - Pre-Closing
Org Chart |
011 |
Exhibit E2 - Post-Closing
Org Chart |
012 |
Exhibit F1 - Redacted
Biographical Affidavits |
013 |
Exhibit F2 - Biographical
Affidavits |
014 |
Exhibit F3 - Applicants'
Directors & Exec Officers |
015 |
Exhibit G1 - Bridge
Facility Commitment Ltr |
016 |
Exhibit G2 - Cigna's 8-K
filed 4/12/18 |
017 |
Exhibit H - Five Year
Projections |
018 |
Exhibit I1 - Pre & Post
Close Directors & Officers Cigna Surv |
019 |
Exhibit I2 - Pre & Post
Close Dirirectors & Officers Expr Surv |
020 |
Exhibit I3 - Pre & Post
Close Dirrectors & Officers of Holdco |
021 |
Exhibit J - Cigna's Annual
Report to Shareholders |
022 |
Exhibit K - Before &
After Balance Sheet |
023 |
Exhibit L - Domestic
Insurer's Latest RBC |
024 |
Exhibit M - Competitive
Impact Statement |
032 |
Cover Letter to Electronic Copy of Public Record |
034 |
Notice of Public Comment Period |
035 |
Exhibit F1 Supplement - Redacted Biographicals |
038 |
Department Letter to Applicant Requesting Additional Information |
039 |
Supplement Materials (Bios, 8-K, Amendment 1 to Agreement and Plan of Merger) |
041 |
Proxy Statement |
042 |
Applicant Response to Department 7/11/18 Letter |
044 |
Department Email to Applicant Requesting Additional Information |
045 |
Response to Department Information Request
|
---|
048
| Redacted Biographical Affidavits
|
---|
049
| Applicant Supplemental Response to Department 7/11/18 Letter
|
---|
051
| Applicant Notice of DOJ Decision
|